Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases

Biological Trace Element Research

Volumn 109, Issue 1, 2006, Pages 15-23

  Lin, Ching Chiang ^a   Huang, Jee Fu ^a   Tsai, Li Yu ^b   Huang, Yeou Lih ^b  

^a FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Copper; Iron; Selenium; Serum; Viral hepatic disease; Zinc

Indexed keywords

BIOLOGICAL MARKER; COPPER; IRON; SELENIUM; TRACE METAL; ZINC;

ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; NONHUMAN; TRACE METAL BLOOD LEVEL; VIRUS HEPATITIS; ZINC BLOOD LEVEL;

ADOLESCENT; ADULT; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; COPPER; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIGENS; HUMANS; IRON; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SELENIUM; TRACE ELEMENTS; ZINC;

HEPATITIS B VIRUS;

EID: 30044446244     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-2094-3-15     Document Type: Article

References (38)

1. M. J. Alter and E. E. Mast, The epidemiology of viral hepatitis in the United States, Gastroenterol. Clin. North Am. 23, 437-455 (1994).
2. P. Pisani, M. Parkin, F. Bray, and J. Ferlay, Estimates of the worldwide mortality from 25 cancers in 1990, Int. J. Cancer 83, 18-29 (1999).
3. K. Huang and S. Lin, Nationwide vaccination: a success story in Taiwan, Vaccine 18, 35-38 (2000).
4. D. S. Chen, G. C. Kuo, J. L. Sung, et al., Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience, J. Infect. Dis. 162, 817-822 (1990).
5. H. H. Lin, T. Y. Lee, D. S. Chen, et al., Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus, J. Pediatr. 111, 877-881 (1987).
6. H. M. Hsu, Epidemiology of Hepatitis B Virus Infection: Taiwan and Promotion with Assessment of Immunoprophylaxis, Hon-Chiang, Taipei, pp. 19-30 (1990).
7. H. H. Lin, J. H. Kao, T. C Chand, H. Y. Hsu, and D. S. Chen, Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan, J. Med. Virol. 69, 466-470 (2003).
8. R. P. Beasley and C. C. Lin, Hepatitis B virus: the major etiology of hepatocellular carcinoma, Cancer 61, 1942-1956 (1986).
9. E. N. Drake and H. H. Sky-Peck, Discriminant analysis of trace element distribution in normal and malignant human tissues, Cancer Res. 49, 4210-4215 (1989).
10. H. H. Sky-Peck, Trace metals and neoplasia, Clin. Physiol. Biochem. 4, 99-111 (1986).
11. S. B. Goldhabe, Trace element risk assessment: essentiality vs. toxicity, Regul. Toxicol. Pharmacol. 38, 232-242 (2003).
12. M. Zowczak, M. Iskra, L. Torlinski, and S. Cofta, Analysis of serum copper and zinc concentrations in cancer patients, Biol. Trace Element Res. 82, 1-8 (2001).
13. M. Kucharzewski, J. Braziewicz, U. Majewska, and S. Gozdz, Selenium, copper, and zinc concentrations in intestinal cancer tissue and in colon and rectum polyps, Biol. Trace Element Res. 92, 1-10 (2003).
14. M. W. Yu, I. S. Horng, K. H. Hsu, Y. C. Chiang, Y. F. Liaw, and C. J. Chen, Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic virus infection, Am. J. Epidemiol. 150, 367-374 (1999).
15. J. Y. N. Lau and T. L. Wright, Molecular virology and pathogenesis of hepatitis B, Lancet 342, 1335-1340 (1993).
16. A. Nakayama, H. Fukuda, M. Ebara, H. Hamasaki, K. Nakajima, and H. Sakurai, A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels, Biol. Pharm. Bull. 25, 426-431 (2002).
17. C. Barandier, S. Tanguy, S. Pucheu, F. Boucher, and J. De Leiris, Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress, Ann. NY Acad. Sci. 874, 138-155 (199).
18. B. Sancak, A. Ünal, S. Candan, U. Coşkun, and N. Günel, Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages, J. Trace Elements Exp. Med. 16, 87-94 (2003).
19. M. P. Rayman, The importance of selenium to human health, Lancet 356, 233-241 (2000).
20. G. N. Schrauzer, Anticarcinogenic effects of selenium, Cell Mol. Life Sci. 57, 1864-1873 (2000).
21. M. B. Irmak, G. Ince, M. Ozturk, and R. Cetin-Atalay, Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Res. 63, 6707-6715 (2003).
22. J. E. Spallholz, L. M. Boylan, and H. S. Larsen, Advances in understanding selenium's role in the immune system, Ann. NY Acad. Sci. 587, 123-139 (1990).
23. E. W. Taylor, R. G. Nadimpalli, and C. S. Ramanathan, Genomic structures of viral agents in relation to the biosynthesis of selenoproteins, Biol. Trace Element Res. 56, 63-91 (1997).
24. F. Fernandez-Banares, E. Cabre, M. Esteve, et al., Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status, Am. J. Gastroenterol. 97, 2103-2108 (2002).
25. G. Gur, Y. Bayraktar, D. Ozer, M. Ozdogan, and B. Kayhan, Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus, Hepato-Gasteroenterology 45, 472-476 (1998).
26. D. G. Barceloux. Zinc, Clin. Toxicol. 37, 279-292 (1999).
27. S. R. Powell, The antioxidant properties of zinc, J. Nutr. 130, 1447-1454 (2000).
28. N. Takeaki, T. Hitoshi, H. Yoshiaki, et al., The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients, Biol. Trace Element Res. 58, 65-76 (1997).
29. E. Ho, Zinc deficiency, DNA damage and cancer risk, J. Nutr. Biochem. 15, 572-578 (2004).
30. T. Wu, C. T. Sempos, J. L. Freudenheim, P. Muti, and E. Smit, Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann. Epidemiol. 14, 195-201 (2004).
31. K. Grüngreiff, Zinc in liver disease, J. Trace Elements Exp. Med. 15, 67-78 (2002).
32. P. K. Eagon, A. G. Teepe, M. S. Elm, et al., Hepatic hyperplasia and cancer in rats: alterations in copper metabolism, Carcinogenesis 20, 1091-1096 (1999).
33. M. Zowczak, M. Iskra, L. Torlinski, and S. Cofta, Analysis of serum copper and zinc concentrations in cancer patients, Biol. Trace Element Res. 82, 1-8 (2001).
34. B. Florianczyk, Copper and metallothioneins in cancer cells, Ann. Univ. Mariae Curie Sklodowska 58, 390-393 (2003).
35. V. L. Goodman, G. J. Brewer, and S. D. Merajver, Copper deficiency as an anti-cancer strategy, Endocr. Relat. Cancer 11, 255-263 (2004).
36. T. U. Ciftci, B. Ciftci, O. Yis, Y. Guney A. Bilgihan, and M. Ogretensoy, Changes in serum selenium, copper, zinc levels and cu/zn ratio in patients with pulmonary tuberculosis during therapy, Biol. Trace Element Res. 95, 65-71 (2003).
37. J. L. Poo, R. Rosas-Romero, A. C. Montemayor, F. Isoard, and M. Uribe, Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study, J. Gastroenterol. 38, 45-51 (2003).
38. H. Canatan, I. Bakan, M. Akbulut, et al., Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects, Biol Trace Element Res. 100, 117-123 (2004).